Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide

Melissa Rayburg, Alexander Towbin, Hong Yin, Todd Maugans, Barry Maurer, Rajaram Nagarajan, Brian Weiss

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Langerhans cell histiocytosis (LCH) has previously been reported in association with other malignancies. The pathogenesis of LCH and its relationship to other malignancies is poorly understood. We present a novel case of a child who developed an LCH bone lesion while receiving a Phase I protocol therapy with oral fenretinide/Lym-X-Sorb (4-HPR/LXS) powder for neuroblastoma.

Original languageEnglish (US)
Pages (from-to)1111-1113
Number of pages3
JournalPediatric Blood and Cancer
Volume53
Issue number6
DOIs
StatePublished - 2009
Externally publishedYes

Keywords

  • Fenretinide
  • LCH
  • Neuroblastoma
  • New agents
  • Pediatric oncology

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Langerhans cell histiocytosis in a patient with stage 4 neuroblastoma receiving oral fenretinide'. Together they form a unique fingerprint.

  • Cite this